MedTrace Logo

Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women

NCT01724658 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2014-01-29

No results posted yet for this study

Summary

Additional testosterone undecanoate can improve female sexual function in postmenopausal women which one aspects of quality of life. The dose adjustment can reduce incidence of adverse effects and low cost of treatment with effective outcome.

Conditions

  • Female Sexual Dysfunction

Interventions

DRUG

Testosterone undecanoate

testosterone undecanoate 40 mg orally twice a week

DRUG

placebo

placebo orally twice a week with progynova 1 mg oral daily

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Reuthairat Tungmunsakulchai, MD · Menopause unit of Chulalongkorn hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-04-30
Completion
2013-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724658 on ClinicalTrials.gov